Patent · US Active

Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivative

US10172805B2 · kind B2 · utility

0Cited by

7References

23Claims

0Family size

Assignee

UCB BIOPHARMA SRL · BE

Inventors

Domenico Fanara · Wanze, BE
Frederic Eeckman · Brussels, BE
Monique Berwaer · Montigny-le-Tilleul, BE

Key dates

Filing date	Nov 17, 2009
Grant date	Jan 8, 2019
Priority date	—
Expiry date	Jun 2, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D207/27
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.